Search results
Individual investors in Sera Prognostics, Inc. (NASDAQ:SERA) are its biggest bettors, and their bets...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Sera Prognostics, Inc. (NASDAQ:SERA) should be aware of the most powerful...
While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over Sera Prognostics by retail investors implies that the general...
Greek Organisation of Football Prognostics SA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 6 months agoGreek Organisation of Football Prognostics SA (GOFPY) recently announced a dividend of $0.54 per...
Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 1 month agoSera Prognostics (SERA) might move higher on growing optimism about its earnings prospects, which is...
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoSera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript March 20, 2024 Sera...
Is Sera Prognostics (NASDAQ:SERA) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Here's Why We're Watching Sera Prognostics' (NASDAQ:SERA) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 7 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Chief Scientific Officer John Boniface Sells 22,163 Shares of Sera Prognostics Inc (SERA)
GuruFocus.com via Yahoo Finance· 1 month agoJohn Boniface, Chief Scientific Officer of Sera Prognostics Inc (NASDAQ:SERA), has sold 22,163...
Uproleselan’s failed Phase III AML trial shakes up GlycoMimetics’ future
Clinical Trials Arena via Yahoo Finance· 3 hours agoOn 6 May 2024, US-based biotech GlycoMimetics announced that its E-selectin inhibitor candidate...
Sera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around...
Zacks via Yahoo Finance· 8 months agoSera Prognostics, Inc. (SERA) has become technically an oversold stock now, which implies exhaustion...